[1]
G. Rodrigues, X. Yao, A. D. Loblaw, M. Brundage, and J. L. Chin, “Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: a systematic review”, CUAJ, vol. 7, no. 11-12, pp. 463–70; e783, Dec. 2013.